Thailand and GHIT Fund join forces to tackle infectious diseases
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
CEO Stéphane Bancel framed the changes as essential to scaling the business
Targeting deadly drug-resistant acinetobacter infections
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
Subscribe To Our Newsletter & Stay Updated